LY2857785 is a type I reversible and competitive ATP kinase inhibitor against CDK9(IC50=0.011 ?M) and also inhibits other transcription kinases CDK8(IC50=0.016 ?M) and CDK7 (IC50=0.246 ?M).
choosing a selection results in a full page refresh
Product has been added to your wishlist.
You can view your wishlist by creating or login account.
Please create account through ##customer_email## email
